The Importance Of Selecting Packaging Components: A Practical Checklist For Emerging Biotechs

By Abigail Hisler, Strategic Marketing Director, Biologics

New drug developers, juggling a multitude of tasks, can sometimes underestimate the significance of choosing the right packaging system. This selection process might be viewed as less complex than it truly is, or there might simply not be enough internal resources to properly research and choose a container closure system. As a result, packaging development gets pushed back to later stages, like Phase 2 or 3, or entirely outsourced to a CDMO.

However, for companies of all sizes, prioritizing packaging development from the outset of drug development is crucial. This proactive approach allows for the early identification of potential delays caused by packaging and the development of strategies to mitigate those risks, ultimately ensuring a smoother launch.

In this article, explore five key considerations in selection components for your injectable drug product.